InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Kamran Alam, Chief Financial Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 12 open-market SEC Form 4 transactions: 0 purchases worth $0 and 12 sales worth $1.4M, reported from Aug 18, 21 to Feb 4, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 4, 26 | TSHATaysha Gene Therapies, Inc. | SELL | 1.7K | $4.52 | $7K |
| Jan 26, 26 | TSHATaysha Gene Therapies, Inc. | SELL | 23.8K | $4.61 | $110K |
| Jan 23, 26 | TSHATaysha Gene Therapies, Inc. | SELL | 79.0K | $4.75 | $375K |
| Aug 21, 25 | TSHATaysha Gene Therapies, Inc. | SELL | 54.5K | $2.85 | $155K |
| Aug 24, 23 | TSHATaysha Gene Therapies, Inc. | SELL | 33.0K | $2.33 | $77K |
| Aug 23, 22 | TSHATaysha Gene Therapies, Inc. | SELL | 3.3K | $3.47 | $12K |
| Aug 22, 22 | TSHATaysha Gene Therapies, Inc. | SELL | 9.7K | $3.50 | $34K |
| Aug 19, 22 | TSHATaysha Gene Therapies, Inc. | SELL | 11.5K | $3.75 | $43K |
| Aug 18, 22 | TSHATaysha Gene Therapies, Inc. | SELL | 7.5K | $3.87 | $29K |
| Aug 20, 21 | TSHATaysha Gene Therapies, Inc. | SELL | 9.7K | $17.14 | $163K |
| Aug 19, 21 | TSHATaysha Gene Therapies, Inc. | SELL | 9.4K | $17.11 | $154K |
| Aug 18, 21 | TSHATaysha Gene Therapies, Inc. | SELL | 11.2K | $17.35 | $194K |